The Specialty Pharmaceutical Summits focus on the identification and dissemination of emerging clinical evidence across specialty therapeutics, with an emphasis on uncovering new clinical, operational, and economic value opportunities. The magnitude and rapid pace of expansion within specialty therapeutics—coupled with increasing treatment complexity, the use of multiple lines of therapy, and evolving considerations for treatment sequencing—demand thoughtful oversight across an increasingly intricate clinical and operational landscape. Concurrent advances in diagnostics and the accelerating evolution of precision medicine further position pharmacists to play a central role in individualized treatment selection and outcomes optimization.

By design, these regional summits convene subject matter experts and local healthcare leaders to examine both clinical and economic considerations across the expanding specialty therapeutics landscape, including oncology, select high-impact specialty areas, and rapidly emerging rare conditions. Summit content emphasizes the translation of emerging clinical evidence into real-world practice and the adoption of innovative therapeutic options, while highlighting the critical role of pharmacists in optimizing patient outcomes and medical practice sustainability.